Synergy Pharmaceuticals (SGYP) Rumor Mill Cranks Up Following Allergan CEO Comments

August 8, 2016 9:59 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

The rumor mill in Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) is cranking again this morning following comments from rumored suitor Allergan (NYSE: AGN) on its conference call today.

On the call, Allergan CEO said the company isn't focused on or looking at large deals. This suggests to some that smaller tuck-in deals would be the top priority (i.e. SGYP-type deals)

Roche and Shire (Nasdaq: SHPG) are also seen as a possible suitors for Synergy.

Shares of SGYP are up 2.2% to $4.66 in early trade.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Rumors, Trader Talk

Add Your Comment